IndexIQ Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$267K Sell
4,696
-48,145
-91% -$2.58M 0.01% 1002
2021
Q4
$2.72M Buy
52,841
+937
+2% +$46K 0.09% 197
2021
Q3
$2.57M Sell
51,904
-521
-1% -$28.3K 0.09% 210
2021
Q2
$2.99M Buy
52,425
+431
+0.8% +$25.2K 0.1% 187
2021
Q1
$3.16M Buy
51,994
+47,896
+1,169% +$2.64M 0.11% 158
2020
Q4
$219K Buy
4,098
+1,931
+89% +$100K 0.01% 876
2020
Q3
$102K Buy
2,167
+1,306
+152% +$67K ﹤0.01% 923
2020
Q2
$45K Buy
861
+759
+744% +$39.1K ﹤0.01% 935
2020
Q1
$5K Buy
102
+2
+2% +$104 ﹤0.01% 884
2019
Q4
$5K Buy
+100
New +$5.17K ﹤0.01% 715

Other funds holding CAH

IndexIQ Advisors's CAH Position: Q1 2022 in Review

IndexIQ Advisors reduced its Cardinal Health (CAH) stake by 91% in Q1 2022, selling an estimated $2.58M and leaving 4,696 shares worth $267K. The position accounts for 0.01% of the portfolio, ranked #1002.

IndexIQ Advisors first reported a position in CAH in Q4 2019 and has held it in 10 quarters since. The position peaked at $3.16M in Q1 2021. 782 funds tracked by Wall St. Rank hold CAH as of Q1 2022.

  • IndexIQ Advisors held 4,696 shares of Cardinal Health worth $267K as of Q1 2022.
  • IndexIQ Advisors sold 48,145 Cardinal Health shares in Q1 2022, an estimated $2.58M.
  • Cardinal Health made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1002 holding.
  • IndexIQ Advisors first reported a position in Cardinal Health in Q4 2019 and has held it in 10 quarters since.
  • IndexIQ Advisors's Cardinal Health position peaked at $3.16M in Q1 2021.
  • 782 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.